Related Experiment Video
Updated: Sep 12, 2026
Chronic Salmonella Infected Mouse Model
Published on: June 1, 2010
Studies of a receptor for FP3-phage in Salmonella minnesota R595
Abstract:
The adsorption rate constant of the phage FP3 to sensitive S. minnesota R595 strain was used to evaluate the inactivating capacity towards phage FP3 exhibited by isolated glycolipid and free lipid A. The results suggest that phage FP3 receptor is localized in the glycolipid structure. Phage FP3 is not adsorbed on the other Re mutant cells, Proteus R45, but respective products: glycolipid and free lipid A from R45 exhibitory the inhibition capacity towards phage FP3, comparable to the activity of the products derived from the host strain; the minimal PhI50 concentration of glycolipids is 7.8 and 15.6 microgram/ml respectively.
Insights
This study found that the phage FP3 receptor is located in the glycolipid structure of S. minnesota R595. Glycolipids and lipid A from both host and non-host strains inhibit phage FP3 activity.
Area of Science:
- Microbiology
- Virology
- Biochemistry
Background:
- Bacteriophages are viruses that infect bacteria and are potential therapeutic agents.
- Understanding phage-host interactions is crucial for phage therapy development.
- Lipid A and glycolipids are key components of bacterial outer membranes and can act as phage receptors.
Purpose of the Study:
- To investigate the inactivating capacity of glycolipid and free lipid A on phage FP3.
- To determine the localization of the phage FP3 receptor on the bacterial surface.
- To compare the inhibitory activity of glycolipids and lipid A from different bacterial strains.
Main Methods:
- Adsorption rate constant measurements of phage FP3 to S. minnesota R595.
- Evaluation of isolated glycolipid and free lipid A for phage FP3 inactivating capacity.
- Testing phage FP3 adsorption on Proteus R45 Re mutant cells.
- Determination of minimal PhI50 concentration for glycolipids.
Main Results:
- Phage FP3 receptor is localized within the glycolipid structure of S. minnesota R595.
- Isolated glycolipid and free lipid A exhibited inactivating capacity towards phage FP3.
- Phage FP3 did not adsorb to Proteus R45 Re mutant cells.
- Glycolipids and lipid A from Proteus R45 showed inhibitory activity comparable to the host strain.
Conclusions:
- The glycolipid structure serves as the receptor for phage FP3.
- Bacterial glycolipids and lipid A possess phage inhibitory properties, suggesting potential for broader applications.
- Further research into these inhibitory mechanisms could inform phage therapy strategies.
